Clinical Trial Update: Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma [NA]

View source ↗

Summary

A clinical trial is evaluating the PET/CT tracer Al18F-NOTA-LM3 in patients with pheochromocytoma and paraganglioma, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraganglioma
• Pheochromocytoma

Drugs mentioned

• Al18F-NOTA-LM3 (Al18F-NOTA-LM3)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Pheochromocytoma/Paraganglioma (PPGL) | NA | Status: RECRUITING